Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Industry News
Blog|Nov 3 2025
Meet the Community: Melanie
Community
News|Oct 31 2025
FA Symposium Recordings Now Available!
Education | FARA News
Blog|Oct 27 2025
2025 FA Symposium and RideATAXIA Philly Recap
Events
Blog|Oct 20 2025
Meet the Community: Jack Tyson
Community
Blog|Oct 13 2025
Meet the Community: Michael Gehr
Community
Blog|Oct 8 2025
FA & Speech Toolkit
Advocacy
News|Oct 7 2025
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy